TIANYIN PHARMACEUTICAL CO IN's ticker is TPIY and the CUSIP is 88630M104. A total of 1 filers reported holding TIANYIN PHARMACEUTICAL CO IN in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $0 | – | 745,175 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 745,175 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 745,175 | 0.0% | 0.00% | – |
| Q2 2017 | $0 | -100.0% | 745,175 | 0.0% | 0.00% | -100.0% |
| Q1 2017 | $119,000 | 0.0% | 745,175 | 0.0% | 0.08% | -12.5% |
| Q4 2016 | $119,000 | 0.0% | 745,175 | 0.0% | 0.09% | -8.3% |
| Q3 2016 | $119,000 | +7.2% | 745,175 | 0.0% | 0.10% | +3.2% |
| Q1 2016 | $111,000 | -10.5% | 745,175 | 0.0% | 0.09% | -8.8% |
| Q4 2015 | $124,000 | -63.0% | 745,175 | 0.0% | 0.10% | -51.2% |
| Q3 2015 | $335,000 | -3.7% | 745,175 | 0.0% | 0.21% | -26.1% |
| Q2 2015 | $348,000 | -48.1% | 745,175 | -50.0% | 0.28% | -1.0% |
| Q1 2015 | $670,000 | +23.2% | 1,490,350 | +100.0% | 0.29% | -34.3% |
| Q4 2014 | $544,000 | +7.9% | 745,175 | -5.4% | 0.44% | +44.5% |
| Q3 2014 | $504,000 | -56.0% | 787,400 | -50.5% | 0.30% | -53.6% |
| Q2 2014 | $1,145,000 | -49.0% | 1,590,669 | -30.4% | 0.65% | -49.5% |
| Q1 2014 | $2,244,000 | -45.0% | 2,284,900 | -55.7% | 1.29% | -77.2% |
| Q4 2013 | $4,079,000 | +2.6% | 5,157,658 | -2.7% | 5.65% | +0.4% |
| Q3 2013 | $3,975,000 | +52.2% | 5,300,008 | +0.0% | 5.63% | +29.9% |
| Q2 2013 | $2,612,000 | – | 5,298,008 | – | 4.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| POPE ASSET MANAGEMENT, LLC | 745,175 | $111,000 | 0.09% |
| Cable Hill Partners, LLC | 57,000 | $8,000 | 0.01% |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 333,300 | $53,000 | 0.00% |
| UBS Group AG | 5,132 | $1,000 | 0.00% |
| Renaissance Technologies | 827,600 | $124,000 | 0.00% |